Clinical Trials Browser

Phase 2 × Colitis × Dermatologic × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

NCT04305145 2026-01-29

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Phase 2 Active not recruiting

Colitis, Melanoma, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions